Retrograde Gene Delivery to Hypoglossal Motoneurons Using Adeno-Associated Virus Serotype 9

被引:35
|
作者
ElMallah, Mai K. [2 ]
Falk, Darin J. [2 ,3 ]
Lane, Michael A. [4 ]
Conlon, Thomas J. [3 ]
Lee, Kun-Ze
Shafi, Nadeem I. [2 ]
Reier, Paul J. [4 ]
Byrne, Barry J. [2 ,3 ]
Fuller, David D. [1 ]
机构
[1] Univ Florida, Dept Phys Therapy, McKnight Brain Inst, Coll Publ Hlth & Hlth Profess, Gainesville, FL 32610 USA
[2] Univ Florida, Coll Med, Dept Pediat, Gainesville, FL 32610 USA
[3] Univ Florida, Powell Gene Therapy Ctr, Gainesville, FL 32610 USA
[4] Univ Florida, Coll Med, Dept Neurosci, Gainesville, FL 32610 USA
基金
美国国家卫生研究院;
关键词
GLYCOGEN-STORAGE-DISEASE; INFANTILE POMPE DISEASE; AAV VECTOR; SPINAL-CORD; EFFICIENT TRANSDUCTION; NONHUMAN-PRIMATES; VIRAL DELIVERY; MOTOR-NEURONS; MOUSE-BRAIN; PHASE-I;
D O I
10.1089/hgtb.2012.009
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Retrograde viral transport (i.e., muscle to motoneuron) enables targeted gene delivery to specific motor pools. Recombinant adeno-associated virus serotype 9 (AAV9) robustly infects motoneurons, but the retrograde transport capabilities of AAV9 have not been systematically evaluated. Accordingly, we evaluated the retrograde transduction efficiency of AAV9 after direct tongue injection in 129SVE mice as well as a mouse model that displays neuromuscular pathology (Gaa(-/-)). Hypoglossal (XII) motoneurons were histologically evaluated 8 weeks after tongue injection with AAV9 encoding green fluorescent protein (GFP) with expression driven by the chicken beta-actin promoter (1 x 10(11) vector genomes). On average, GFP expression was detected in 234 +/- 43 XII motoneurons 8 weeks after AAV9-GFP tongue injection. In contrast, tongue injection with a highly efficient retrograde anatomical tracer (cholera toxin beta subunit, CT-beta) resulted in infection of 818 +/- 88 XII motoneurons per mouse. The retrograde transduction efficiency of AAV9 was similar between the 129SVE mice and those with neuromuscular disease (Gaa(-/-)). Routine hematoxylin and eosin staining and cluster of differentiation (CD) immunostaining for T cells (CD3) indicated no persistent inflammation within the tongue or XII nucleus after AAV9 injection. Additional experiments indicated no adverse effects of AAV9 on the pattern of breathing. We conclude that AAV9 can retrogradely infect a significant portion of a given motoneuron pool in normal and dystrophic mice, and that its transduction efficiency is approximately 30% of what can be achieved with CT-beta.
引用
收藏
页码:148 / 156
页数:9
相关论文
共 50 条
  • [31] Complexation of recombinant adeno-associated virus with polyelectrolytes for gene delivery
    Hsu, P.
    Yang, Y. W.
    HUMAN GENE THERAPY, 2010, 21 (10) : 1403 - 1404
  • [32] Adeno-associated virus vector as a platform for gene therapy delivery
    Wang, Dan
    Tai, Phillip W. L.
    Gao, Guangping
    NATURE REVIEWS DRUG DISCOVERY, 2019, 18 (05) : 358 - 378
  • [33] POTENTIAL OF PERIPHERAL NERVE GENE THERAPY USING A NOVEL ADENO-ASSOCIATED VIRUS SEROTYPE 2.5
    Siddiqui, Ahad
    Wang, Huan
    Schwab, Stephan
    Knorr, Sarah
    Amador, Rodolfo De la Vega
    Coenen, Michael
    Madigan, Nicolas
    Evans, Christopher
    Windebank, Anthony
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2024, 29 : S187 - S188
  • [34] Fighting Blindness with Adeno-Associated Virus Serotype 8
    Auricchio, Alberto
    HUMAN GENE THERAPY, 2011, 22 (10) : 1169 - 1170
  • [35] Structural Insights into Adeno-Associated Virus Serotype 5
    Govindasamy, Lakshmanan
    DiMattia, Michael A.
    Gurda, Brittney L.
    Halder, Sujata
    McKenna, Robert
    Chiorini, John A.
    Muzyczka, Nicholas
    Zolotukhin, Sergei
    Agbandje-McKenna, Mavis
    JOURNAL OF VIROLOGY, 2013, 87 (20) : 11187 - 11199
  • [36] Successful gene transfer using adeno-associated virus vectors into the kidney: Comparison among adeno-associated virus serotype 1-5 vectors in vitro and in vivo
    Takeda, S
    Takahashi, M
    Mizukami, H
    Kobayashi, E
    Takeuchi, K
    Hakamata, Y
    Kaneko, T
    Yamamoto, H
    Ito, C
    Ozawa, K
    Ishibashi, K
    Matsuzaki, T
    Takata, K
    Asano, Y
    Kusano, E
    NEPHRON EXPERIMENTAL NEPHROLOGY, 2004, 96 (04): : E119 - E126
  • [37] Adeno-Associated Virus Serotype 2-hCHM Subretinal Delivery to the Macula in Choroideremia
    Aleman, Tomas S.
    Huckfeldt, Rachel M.
    Serrano, Leona W.
    Pearson, Denise J.
    Vergilio, Grace K.
    McCague, Sarah
    Marshall, Kathleen A.
    Ashtari, Manzar
    Doan, Tu M.
    Weigel-DiFranco, Carol A.
    Biron, Bethany S.
    Wen, Xiao-Hong
    Chung, Daniel C.
    Liu, Emily
    Ferenchak, Kevin
    Morgan, Jessica I. W.
    Pierce, Eric A.
    Eliott, Dean
    Bennett, Jean
    Comander, Jason
    Maguire, Albert M.
    OPHTHALMOLOGY, 2022, 129 (10) : 1177 - 1191
  • [38] Transduction Profile of the Marmoset Central Nervous System Using Adeno-Associated Virus Serotype 9 Vectors
    Matsuzaki, Yasunori
    Konno, Ayumu
    Mukai, Ryo
    Honda, Fumiaki
    Hirato, Masafumi
    Yoshimoto, Yuhei
    Hirai, Hirokazu
    MOLECULAR NEUROBIOLOGY, 2017, 54 (03) : 1745 - 1758
  • [39] Transduction Profile of the Marmoset Central Nervous System Using Adeno-Associated Virus Serotype 9 Vectors
    Yasunori Matsuzaki
    Ayumu Konno
    Ryo Mukai
    Fumiaki Honda
    Masafumi Hirato
    Yuhei Yoshimoto
    Hirokazu Hirai
    Molecular Neurobiology, 2017, 54 : 1745 - 1758
  • [40] Gene Therapy Using Adeno-Associated Virus Vectors
    Daya, Shyam
    Berns, Kenneth I.
    CLINICAL MICROBIOLOGY REVIEWS, 2008, 21 (04) : 583 - 593